Skip to main content
logo
Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
10.25
-0.06 (-0.58%)
At close: Apr 7, 2026, 4:00 PM EDT
10.25
0.00 (0.00%)
After-hours: Apr 7, 2026, 5:37 PM EDT

Immatics Revenue

In the year 2025, Immatics had annual revenue of 48.27M EUR, down -69.03%. Immatics had revenue of 19.76M in the quarter ending December 31, 2025, a decrease of -64.87%.

Revenue (ttm)
48.27M EUR
Revenue Growth
-69.03%
P/S Ratio
24.25
Revenue / Employee
67,885 EUR
Employees
711
Market Cap
1.37B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202548.27M-107.57M-69.03%
Dec 31, 2024155.84M101.84M188.60%
Dec 31, 202354.00M-118.83M-68.76%
Dec 31, 2022172.83M138.07M397.17%
Dec 31, 202134.76M3.51M11.23%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Iovance Biotherapeutics263.50M
Monte Rosa Therapeutics123.67M
Viridian Therapeutics70.85M
Wave Life Sciences42.73M
Zenas BioPharma10.00M
Taysha Gene Therapies9.77M
AtaiBeckley4.09M
Revenue Rankings

IMTX News

More News